Dr Nyree Myatt

Profile

Since joining the Queen Mary medical school in 2020 as a lecturer on the MBBS, I meet students on year one, year two and the graduate entry programme (GEP)  on an almost daily basis. I am the co-module lead for MET1, MET2 and DMG (Digestion, Metabolism and Growth). In addition to delivering biochemistry lectures, I am also a problem-based learning (PBL) tutor on many different modules across years one and two. Part of my role as PBL tutor is being the first port of call for any students needing support.

Before joining Queen Mary, I managed and lectured on biomedical science degree programmes in  further education colleges in south and east London, gaining a PGCE via Greenwich university. Prior to lecturing, I carried out research. I was a post-doctoral research fellow firstly at the Institute of Ophthalmology (UCL) where I was investigating uveal melanoma (eye cancer). My second post-doctoral position was at St George’s Hospital Medical School where I was investigating Fanconi Anaemia.

My PhD was on cytokine mRNA expression following orf virus infection in sheep and I was based in Edinburgh. For my Masters (in Experimental Pathology) at Dundee University ,  I was investigating TNF-α mRNA expression in sarcoidosis. My first degree was combined honours in biochemistry and pharmacology from Leeds University. 

Teaching

My current lecturing centres on teaching biochemistry on the MET1 module. I am also co-module lead for MET2 and DMG on the MBBS.

I teach on the biology module for the clinical certificate in foundation studies (CCFS).

I am a senior tutor for year two students and a MEDPRO tutor for years one and two students.  

I am the principal internal examiner for the graduate entry programme.

I am Chair of the iBSc Pre-Hospital Medicine subject exam board (SEB) and deputy Chair of the Post-Graduate Taught board for IHSE

I am the library representative for the IHSE.

Research

Publications

Myatt, N., Coghill, G., Morrison, K., Jones, D., Cree, I. Detection of tumour necrosis factor-alpha in sarcoidosis and tuberculosis granulomas using in-situ hybridisation. Journal Of Clinical Pathology1994; 47:423-6.

Haig, D., Deane, D., Percival, A., Myatt, N., Thomson, J., Inglis, L., Rothel, J., Seow, H., Wood, P., Miller, H., Reid, H. The cytokine response of afferent lymph following orf virus reinfection of sheep. Veterinary Dermatology 1996; 7:11-20.

Haig, D., Deane, D., Myatt, N., Thomson, J., Entrican, G., Rothel, J., Reid, H. The activation status of ovine CD45R+ and CD45R- efferent lymph T cells after orf virus reinfection. Journal of Comparative Pathology 1996; 115:163-74.

Haig, D., McInnes, C., Deane, D., Lear, A., Myatt, N., Reid, H., Rothel, J., Seow, H., Wood, P., Lyttle, D. Cytokines and their inhibitors in orf virus infection. Veterinary Immunology and Immunopathology 1997; 54: 261-7.

Myatt, N., Cree, I., Kurbacher, C., Foss, A., Hungerford, J., Plowman, P. The ex-vivo chemosensitivity profile of choroidal melanoma. Anti-Cancer Drugs 1997; 8: 756-62.

Neale, M., Myatt, N., Cree, I., Kurbacher, C., Foss, A., Hungerford, J., Plowman, P. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. British Journal of Cancer 1999; 79: 1487-93.

Chana, J., Wilson, G., Cree, I., Alexander, R., Myatt, N., Neale, M., Foss, A., Hungerford, J. C-myc, p53 and Bcl-2 expression and clinical outcome in uveal melanoma. The British Journal of Ophthalmology 1999; 83: 110-4.

Cree, I., Neale, M., Myatt, N., de Takats, P., Hall, P., Grant, J., Kurbacher, C., Reinhold, U., Neuber, K., MacKie, R. Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. Anti-Cancer Drugs 1999: 10: 437-44.

Satherley, K., de Souza, L., Neale, M., Alexander, R., Myatt, N., Foss, A., Hungerford, J., Hickson, I., Cree, I. Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma. The Journal of Pathology 2000; 192: 174-81.

Myatt, N., Aristodemou P., Neale, M., Foss, A., Hungerford, J., Bhattacharya, S., Cree, I. Abnormalities of the transforming growth factor-beta pathway in occular melanoma. The Journal of Pathology 2000; 192:511-8.

Neale, M., Myatt, N., Khoury, G., Weaver, P., Lamont, A., Hungerford, J., Kurbacher, C., Hall, P., Corrie, P., Cree, I. Comparison of the ex-vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Research 2001; 11: 601-9

Boyd, S., Tan, D., de Souza, L., Neale, M., Myatt, N., Alexander, R., Robb., M., Hungerford, J., Cree, I. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. The British Journal of Ophthalmology 2001; 86: 440-7.

Rutherford, T., Myatt, N., Gibson, F., Clarke, A. The Fanconi anaemia cell line HSC536N is not sensitive to interferon –gamma and does not cleave PARP in response to FAS- mediated cell killing. Blood 2002; 2627-8.

Clarke, AA., Gibson, F., Scott, J., Myatt, N., Rutherford, T. Fanconi’s anaemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies. Haematologica 2004;89:11-20.

“Online proctored exams”. Abstract for poster presented to ASME 2020

“Let’s go round again: group support for repeating year one MBBS students” Abstract submitted for ASME conference 2023 (ASM2023-134)